|
|
Recent Swiss Stock Market News
-
[2010/2/24]
Nestlé: Full Year Results and Analysts Reactions
In 2009, the Nestlé Group’s sales reached CHF 107.6 billion, with organic growth of 4.1%, including real internal growth of 1.9%. Foreign exchange impacted sales by -5.5% and divestitures, net of acquisitions, by -0.7...
-
[2010/2/19]
Givaudan: Full Year Results and Analysts Reactions
In 2009, Givaudan group sales totalled CHF 3,959 million, an increase of 1.4% in local currencies and a decrease of 3.1% in Swiss francs compared to the previous year. On a comparable basis (in local currencies and excluding the...
-
[2010/2/19]
Swiss Re: Full Year Results and Analysts Reactions
Swiss Re returned to profit in 2009, reporting net income of CHF 506 million, compared to a loss of CHF 864 million in the prior year. Net income was impacted by impairments of CHF 2 billion, mainly in the s...
-
[2010/2/12]
Credit Suisse: Full Year Results and Analysts Reactions
Credit Suisse Group achieved a strong performance in 2009, with net income of CHF 6.7 billion, a return on equity of 18.3% and net new assets of CHF 44.2 billion. The tier 1 ratio was 16.3%. In 4Q09, the Group recorded net incom...
-
[2010/2/11]
UBS: Full Year Results and Analysts Reactions
Net loss attributable to shareholders decreased to CHF 2,736 million for full-year 2009 from CHF 21,292 million in 2008. Adjusted for the items below, the underlying pre-tax profit for 2009 was CHF 1.4 billion. In 2009, the bigg...
-
[2010/2/10]
Zurich Financial Services: Bordier Confirm PLUS
The group’s Q4 and annual results for 2009 were marginally better than the already high expectations. Their quality is in fact well above average in recurring terms. As a result the group can afford the luxury of rewarding i...
-
[2010/2/6]
Petroplus: Helvea Cuts Target Price To CHF20
Petroplus 2010 refinery market outlook has pleased Helvea, which, however, keeps its bearish longterm view on the gasoline market, cutting its price target for the Swiss-listed refiner to CHF20 from CHF24. Broker also says that...
-
[2010/2/6]
Zurich: Full Year Results and Analysts Reactions
Zurich Financial Services Group (Zurich) reported today continued strong operating performance, sustained profitability in all its core business segments and targeted growth in profitable market segments, particularly in Global ...
-
[2010/2/6]
Roche: Full Year Results and Analysts Reactions
Roche reported a decline in full-year net profit on expenses related to the takeover of California-based biotech firm Genentech last year, but said brisk sales of flu drug Tamiflu and cancer medicines drove revenue higher. Sal...
-
[2010/1/31]
Morgan Stanley Ups Roche, Novartis Price Targets
Morgan Stanley raises its Roche price target to CHF227 from CHF200 and its Novartis target to CHF61 from CHF49.50. Morgan Stanley cites Roche as one of its favored stocks in the European pharma industry and keeps an overweight ...
|
|
|